Finasteride Cost in Alaska 2026: Cash Pay, Insurance, and Compounded Options

What Does Finasteride Actually Cost in Alaska in 2026?

Generic finasteride at Alaska retail pharmacies costs approximately $12 per month when you apply a free GoodRx or RxSaver discount card at checkout. Without any discount, the same 30-tablet supply of 1 mg generic finasteride can reach $30 to $50 at chain pharmacies. Merck's brand-name Propecia carries a list price of roughly $85 per month, which almost no cash-pay patient should pay given the availability of therapeutically identical generics.

Finasteride is a type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved the 1 mg formulation for male androgenetic alopecia (AGA) in 1997 and the 5 mg formulation (Proscar) for benign prostatic hyperplasia (BPH) in 1992 [1]. Both doses are now available as low-cost generics, which is why cash-pay prices in Alaska have fallen well below the brand list price.

Kaufman et al. conducted a key two-year, double-blind, placebo-controlled trial (N=1,553) showing that finasteride 1 mg daily produced statistically significant increases in hair count and scalp coverage scores compared with placebo, with 83% of treated men maintaining or increasing hair count at 24 months versus 28% on placebo [2]. That efficacy data, published in the Journal of the American Academy of Dermatology, anchors most prescribers' confidence in long-term finasteride therapy.

For Alaskans who take finasteride for BPH rather than AGA, the 5 mg tablet is the prescribed dose. Splitting a 5 mg tablet into quarters is a common off-label cost-reduction strategy sometimes discussed between patients and their physicians, though this approach should only be done under clinical guidance because tablet scoring varies by manufacturer [3].

The McKesson Drug Topics 2026 national average wholesale price (AWP) for generic finasteride 1 mg (30 tablets) sits near $18, and Alaska retail markups typically place final out-of-pocket cost between $10 and $15 with a discount card applied. Patients in Anchorage, Fairbanks, and Juneau have reported consistent prices at this level at Walgreens, Fred Meyer Pharmacy, and Carrs Pharmacy.

Does Alaska Medicaid Cover Finasteride?

Alaska Medicaid does not cover finasteride for androgenetic alopecia, and coverage for the BPH indication requires prior authorization that is frequently denied based on the Alaska Medicaid Preferred Drug List (PDL) as of 2026. Patients relying on Denali KidCare or standard Alaska Medicaid should assume no reimbursement and plan to pay out of pocket [4].

The Alaska Division of Health Care Services updates its PDL quarterly. Finasteride does not appear on the covered formulary for cosmetic or hair-loss purposes under any Alaska Medicaid category. For BPH, alpha-blockers such as tamsulosin are listed as preferred first-line agents, which means finasteride typically requires a step-therapy failure before prior authorization may even be considered.

Patients enrolled in Alaska Medicaid who have a documented BPH diagnosis and who have already failed tamsulosin or doxazosin can submit a prior authorization request to the Alaska Division of Behavioral Health and the pharmacy benefits manager. Approvals are not guaranteed. The American Urological Association 2021 guideline on BPH management does note that 5-alpha-reductase inhibitors are appropriate for patients with enlarged prostate glands confirmed by imaging, though it does not mandate them as first-line agents [5].

If you are a dual-eligible beneficiary (Medicare and Medicaid), Medicare Part D plans vary by formulary. Some Part D plans in Alaska place generic finasteride on Tier 1 or Tier 2 with copays of $5 to $15 per month. Reviewing the specific formulary of your Part D plan through the Medicare Plan Finder tool at cms.gov is the most direct way to confirm coverage.

Is Compounded Finasteride Legal in Alaska?

Compounded finasteride is legal in Alaska when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. Alaska follows federal and state pharmacy law governing 503A compounders, and finasteride is not on the FDA's 503A prohibited substances list [6].

A 503A pharmacy compounds medications for individual patients based on prescriber orders. This differs from a 503B outsourcing facility, which produces large batches for institutional clients. Most telehealth platforms and local compounding pharmacies in Alaska operate as 503A facilities.

Compounded finasteride in Alaska typically costs around $45 per month. Common compounded formulations include finasteride combined with minoxidil in a topical solution or spray, which some patients prefer because topical delivery may reduce systemic DHT suppression and associated sexual side effects compared with oral dosing [7]. A 2021 randomized trial published in the Journal of the American Academy of Dermatology (N=90) found that topical finasteride 0.25% spray applied once daily produced scalp DHT reduction comparable to oral finasteride 1 mg while maintaining significantly lower serum DHT levels, suggesting a potentially better systemic safety profile [7].

The Alaska Board of Pharmacy licenses and inspects compounding pharmacies operating within the state. Prescriptions for compounded finasteride must be written by a provider licensed in Alaska (or authorized to prescribe via telehealth under Alaska statute AS 08.64.107). The prescription cannot be a refill of a commercially available product unless the compounded version provides a clinically significant difference documented in the patient record [8].

Patients should verify any online pharmacy's 503A license through the Alaska Division of Corporations, Business and Professional Licensing before purchasing compounded finasteride. Unlicensed or gray-market suppliers carry meaningful quality and contamination risks.

Which Private Insurance Plans Cover Finasteride in Alaska?

Private insurance coverage for finasteride in Alaska depends entirely on the specific plan formulary, and AGA coverage is commonly excluded as cosmetic [9]. BPH coverage is more frequently approved but still subject to step therapy and prior authorization requirements.

Premera Blue Cross and Moda Health are among the largest commercial insurers operating in Alaska. Both carriers treat finasteride for AGA as a cosmetic benefit exclusion in most standard individual and group plans. BPH indications are handled differently: Premera's 2025 formulary lists generic finasteride 5 mg on Tier 2 with a typical copay of $10 to $20 per 30-day supply after deductible, subject to prior authorization.

Employer-sponsored plans vary even more widely. A plan that self-insures under ERISA has discretion to include or exclude finasteride at any dose for any indication. Employees covered by such plans should request the Summary of Benefits and Coverage (SBC) document from their HR department and look specifically for language about "cosmetic exclusions" or "hair loss treatments."

The Endocrine Society's 2017 clinical practice guideline on male hypogonadism does not specifically address finasteride formulary classification, but broader guidance on DHT-related conditions affirms that 5-alpha-reductase inhibitors carry FDA-approved indications for BPH and AGA, which insurers may use as the clinical basis for coverage decisions [10].

For patients whose commercial insurance denies coverage, the generic cash price of $12 per month with a discount card will almost always be lower than the insurance copay after deductible in a high-deductible health plan.

How to Get the Cheapest Finasteride in Alaska

The single most effective cost-reduction step for most Alaskans is using a free prescription discount card such as GoodRx, RxSaver, or NeedyMeds at a retail pharmacy that accepts it. These cards are not insurance and work regardless of whether you have insurance [11]. Presenting the card at the pharmacy counter bypasses your insurance billing and applies a pre-negotiated rate that routinely brings generic finasteride 1 mg (30 tablets) to $10 to $15 at Anchorage, Fairbanks, and Juneau locations.

The following decision path helps Alaskans choose the lowest-cost access route:

1. Check GoodRx or RxSaver for your specific ZIP code. If the quoted price is below $15 for a 30-day supply, use that at your local pharmacy. No telehealth visit required if you already have a prescription.
2. If you need a new prescription and do not have a primary care provider, a telehealth visit through a licensed Alaska platform (see next section) generates a prescription that any Alaska pharmacy will fill.
3. If you prefer a topical formulation or a finasteride-minoxidil combination, request a compounded product from a licensed 503A pharmacy. Expect to pay around $45 per month but gain flexibility in formulation.
4. If you have BPH and commercial insurance, request a prior authorization for finasteride 5 mg and document failure of at least one alpha-blocker to satisfy most step-therapy requirements.
5. If you are uninsured and the $12 cash price is still a barrier, apply to the Merck Patient Assistance Program (PAP) at merck.com/patient-assistance-program, which provides Propecia at no cost to qualifying low-income patients.

Splitting a branded Proscar 5 mg tablet into five equal portions is a widely cited off-label cost strategy that brings the per-dose cost of finasteride 1 mg to roughly $3 per month at brand price or under $2 at generic Proscar price. Patients should discuss this with their prescriber, because not all tablet formulations split cleanly, and some coatings may affect absorption when cut [12].

Can You Get Finasteride via Telehealth in Alaska?

Telehealth prescribing of finasteride is fully legal in Alaska. Alaska Statute AS 08.64.107 explicitly permits prescribing via synchronous audio-video telehealth by providers licensed in Alaska, and a physical examination is not required for straightforward AGA diagnosis when the provider documents clinical assessment based on patient history and submitted photographs [13].

Several national telehealth platforms are licensed to prescribe in Alaska, including services focused on men's health and hair loss. A telehealth consultation for finasteride typically costs $20 to $75 for the visit itself, after which the prescription can be sent to any Alaska retail pharmacy or to a 503A compounding pharmacy of the patient's choosing.

Alaska does not require an in-person visit before a telehealth provider can prescribe finasteride. However, providers are expected to perform a medically appropriate evaluation, which for AGA includes reviewing the patient's medical history, current medications (particularly other DHT-related agents), and any history of prostate cancer, liver disease, or hypersensitivity to finasteride [14].

Men with a family history of prostate cancer should discuss the PCPT (Prostate Cancer Prevention Trial, N=18,882) data with their prescriber before starting finasteride. The PCPT showed a 24.8% relative reduction in prostate cancer prevalence over seven years in the finasteride arm versus placebo, but also a higher rate of high-grade tumors in the finasteride group, a finding whose clinical significance remains debated [15]. The FDA updated the finasteride label in 2011 to reflect this risk signal, and prescribers should document this discussion in the patient record [1].

Understanding Finasteride Side Effects That May Affect Your Cost Decision

Side effects are infrequent but real. Finasteride's most discussed adverse effects are sexual in nature: decreased libido, erectile dysfunction, and reduced ejaculate volume each occur in roughly 1% to 4% of men in clinical trials, with most cases resolving after discontinuation [2]. A smaller subset of patients report persistent sexual dysfunction after stopping the drug, sometimes called post-finasteride syndrome, though the mechanistic basis and true prevalence remain under active study [16].

Depression and mood changes have been reported in post-marketing surveillance data. The FDA label includes a warning about these effects, and patients with a pre-existing mood disorder should discuss the risk with their prescribing clinician [1].

These side-effect considerations can affect cost decisions because patients who experience sexual dysfunction may seek phosphodiesterase-5 inhibitors concurrently, adding $10 to $30 per month to total medication costs. Switching to topical finasteride (compounded) is one strategy some clinicians use to maintain hair-loss efficacy while reducing systemic DHT suppression [7].

How the Merck Patient Assistance Program and Savings Cards Work in Alaska

Merck offers a Patient Assistance Program (PAP) for Propecia that covers uninsured or underinsured patients meeting income thresholds, generally at or below 400% of the federal poverty level. Alaska residents can apply directly at merck.com or through a licensed provider who submits the application on the patient's behalf [17].

Merck has also periodically offered a savings card for commercially insured patients that reduces the monthly brand copay to a fixed amount. These offers change, so Alaskan patients should verify current availability directly with Merck before assuming a specific discount. Because generic finasteride is so inexpensive, the savings card provides the most value only for patients specifically requiring brand Propecia for documented reasons.

NeedyMeds and RxAssist maintain databases of patient assistance programs and can be searched by drug name and state. Both resources list programs applicable to Alaska residents and are updated more frequently than many state-level resources [18].

Dosing Reference for Alaska Patients

Finasteride 1 mg orally once daily is the FDA-approved dose for androgenetic alopecia in men. Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets because of the risk of DHT-mediated teratogenicity in male fetuses [1]. This is particularly relevant in Alaska households where a female partner may handle a male patient's medication.

Finasteride 5 mg orally once daily is the FDA-approved dose for BPH. Response for BPH symptom reduction typically requires six months or more of consistent dosing, as documented in the PLESS trial (Proscar Long-Term Efficacy and Safety Study, N=3,040), which showed a 57% reduction in the risk of acute urinary retention and BPH-related surgery over four years compared with placebo [19].

Hair regrowth response for AGA is also gradual. Kaufman et al. documented that statistically significant improvements in hair count were detectable at three months but maximal benefit required 12 to 24 months of uninterrupted therapy [2]. Stopping finasteride typically results in return to baseline hair loss within 12 months, which is a key counseling point for any patient weighing the $12-per-month ongoing cost against intermittent use.